Smartleaf Asset Management’s ResMed RMD Stock Holding History

Smartleaf Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$378K	Sell	1,720 -21	-1%	-$5.23K	0.01%	601
2025 Q4	$423K	Buy	1,741 +183	+12%	+$46.8K	0.02%	570
2025 Q3	$422K	Buy	1,558 +792	+103%	+$216K	0.03%	513
2025 Q2	$195K	Sell	766 -456	-37%	-$109K	0.02%	588
2025 Q1	$269K	Buy	1,222 +46	+4%	+$10.7K	0.03%	492
2024 Q4	$270K	Buy	1,176 +312	+36%	+$75.1K	0.03%	459
2024 Q3	$207K	Buy	864 +480	+125%	+$107K	0.03%	488
2024 Q2	$73.6K	Buy	384 +199	+108%	+$40.4K	0.01%	649
2024 Q1	$36.3K	Buy	+185	New	+$33.9K	0.01%	751

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Smartleaf Asset Management's RMD Position: Q1 2026 in Review

Smartleaf Asset Management reduced its ResMed (RMD) stake by 1.2% in Q1 2026, selling an estimated $5.23K and leaving 1,720 shares worth $378K. The position accounts for 0.01% of the portfolio, ranked #601.

Smartleaf Asset Management first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $423K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Smartleaf Asset Management held 1,720 shares of ResMed worth $378K as of Q1 2026.
Smartleaf Asset Management sold 21 ResMed shares in Q1 2026, an estimated $5.23K.
ResMed made up 0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #601 holding.
Smartleaf Asset Management first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
Smartleaf Asset Management's ResMed position peaked at $423K in Q4 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.